Replies to post #339 on Novocure Ltd (NVCR)

[dstock07734]

I don't think you got the facts correct.

Clearly TTF + SOC delivered the results even worse than SOC. Likewise for the case of TTF + ICI and TTF + DTX except the case PD-L1 expression less than 1%.

The trial was a total failure!

https://www.novocure.com/lunar-phase-3-clinical-trial-demonstrates-statistically-significant-and-clinically-meaningful-extension-in-overall-survival-for-patients-with-metastatic-non-small-cell-lung-cancer-after-platinum-based/